Atlas Trials

Immunological Markers Predictive of Response and Toxicity to Checkpoint Inhibitors in Non-small Cell Lung Cancer

Clinical trial NCT04918836 · UNKNOWN

Trial details

NCT number
NCT04918836
Sponsor
University Hospital, Brest
Status
UNKNOWN
Study type
OBSERVATIONAL
Lung Cancer
Start date
2021-04-08
Primary completion
2021-10-08
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.